N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide

C34H41N7O4S — CID 89353592

IUPACN-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide
SMILESCCCN(C(=O)NCc1ccccc1)N1CC(=O)N([C@H](C)Cc2ccc(OC)cc2)[C@@H]1CN(C=O)Cc1cccc2sc(N)nc12
InChIInChI=1S/C34H41N7O4S/c1-4-17-39(34(44)36-19-26-9-6-5-7-10-26)40-22-31(43)41(24(2)18-25-13-15-28(45-3)16-14-25)30(40)21-38(23-42)20-27-11-8-12-29-32(27)37-33(35)46-29/h5-16,23-24,30H,4,17-22H2,1-3H3,(H2,35,37)(H,36,44)/t24-,30-/m1/s1
InChIKeyBDIMMIRBFIHWPM-AYWVHJORSA-N
MW643.81 g/mol
LogP4.48
Rot. Bonds14

About N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide

N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide (PubChem CID 89353592) has the molecular formula C34H41N7O4S and a molecular weight of 643.81 g/mol. Its IUPAC name is N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide.

Molecular Properties

Compound NameN-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide
PubChem CID89353592
Molecular FormulaC34H41N7O4S
Molecular Weight643.81 g/mol
Exact Mass643.29
IUPAC NameN-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide
SMILESCCCN(C(=O)NCc1ccccc1)N1CC(=O)N([C@H](C)Cc2ccc(OC)cc2)[C@@H]1CN(C=O)Cc1cccc2sc(N)nc12
InChIInChI=1S/C34H41N7O4S/c1-4-17-39(34(44)36-19-26-9-6-5-7-10-26)40-22-31(43)41(24(2)18-25-13-15-28(45-3)16-14-25)30(40)21-38(23-42)20-27-11-8-12-29-32(27)37-33(35)46-29/h5-16,23-24,30H,4,17-22H2,1-3H3,(H2,35,37)(H,36,44)/t24-,30-/m1/s1
InChIKeyBDIMMIRBFIHWPM-AYWVHJORSA-N
XLogP4.48
TPSA124.34 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds14
Heavy Atoms46
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500643.81
LogP ≤ 54.48
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide?
The IUPAC name of N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide (CID 89353592) is N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide.
What is the SMILES notation for N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide?
The canonical SMILES for N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide is CCCN(C(=O)NCc1ccccc1)N1CC(=O)N([C@H](C)Cc2ccc(OC)cc2)[C@@H]1CN(C=O)Cc1cccc2sc(N)nc12.
What is the InChIKey of N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide?
The InChIKey is BDIMMIRBFIHWPM-AYWVHJORSA-N. The full InChI is InChI=1S/C34H41N7O4S/c1-4-17-39(34(44)36-19-26-9-6-5-7-10-26)40-22-31(43)41(24(2)18-25-13-15-28(45-3)16-14-25)30(40)21-38(23-42)20-27-11-8-12-29-32(27)37-33(35)46-29/h5-16,23-24,30H,4,17-22H2,1-3H3,(H2,35,37)(H,36,44)/t24-,30-/m1/s1.
What are the key properties of N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide?
N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide has a molecular weight of 643.81 g/mol, XLogP of 4.48, 14 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2-amino-1,3-benzothiazol-4-yl)methyl]-N-[[(2S)-1-[benzylcarbamoyl(propyl)amino]-3-[(2R)-1-(4-methoxyphenyl)propan-2-yl]-4-oxoimidazolidin-2-yl]methyl]formamide is sourced from PubChem (CID 89353592), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).